Ameriprise
ENZN

Ameriprise’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Ameriprise’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-15,120
Closed -$18K – 4096
2015
Q2 		$18K Hold
15,120
– – ﹤0.01% 3991
2015
Q1 		$16K Sell
15,120
-1,357
-8% -$1.4K ﹤0.01% 3771
2014
Q4 		$17K Sell
16,477
-280
-2% -$294 ﹤0.01% 3665
2014
Q3 		$18K Sell
16,757
-620
-4% -$765 ﹤0.01% 4542
2014
Q2 		$18K Sell
17,377
-4,150
-19% -$3.95K ﹤0.01% 4395
2014
Q1 		$22K Buy
21,527
+10,425
+94% +$10.8K ﹤0.01% 4168
2013
Q4 		$13K Buy
11,102
+2,993
+37% +$4.61K ﹤0.01% 4274
2013
Q3 		$14K Buy
8,109
+540
+7% +$999 ﹤0.01% 4679
2013
Q2 		$15K Buy
+7,569
New +$22.2K ﹤0.01% 4512

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Ameriprise's ENZN Position: Q3 2015 in Review

Ameriprise sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q3 2015, closing a stake of 15,120 shares — an estimated $18K sold.

Ameriprise first reported a position in ENZN in Q2 2013 and held it in 9 quarters. The position peaked at $22K in Q1 2014. 53 funds tracked by Wall St. Rank hold ENZN as of Q3 2015.

  • Ameriprise reported no remaining ENZON PHARMACEUTICALS INC position as of Q3 2015 after selling out during the quarter.
  • Ameriprise sold 15,120 ENZON PHARMACEUTICALS INC shares in Q3 2015, an estimated $18K.
  • Ameriprise first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 9 quarters.
  • Ameriprise's ENZON PHARMACEUTICALS INC position peaked at $22K in Q1 2014.
  • 53 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.